Alpha-Gal Syndrome PBMC

All filters

Sample Attributes

Sample Attributes

Format
Volume / Size
Disease Area

Disease Area

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

5 lots available
Specimen IDSample TypeBag SizePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesEthnic BackgroundBMICMV StatusHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeSample StatusAvailability
Alpha-Gal Syndrome (AGS) PBMC 68262 129558 Female 18-30 Caucasian Cryopreserved 1 mL 10 10M zoely birth control albuterol, PRN vitamin D supplement iron supplement Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 150419; 150420; 150411; 150412; 150413; 150414; 150415; 150416; 150417; 150418PBMCAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)Yesred meat, seasonal23.03NoNoYesNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66675 129531 Male 61+ Caucasian Cryopreserved 1 mL 8 10M Klonidine 0.1 mg QD Valsartan/HCTZ 80/25 mg QD Atorvastatin 40 mg QD Metoprolol 100 mg QD Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 143893; 143894; 143895; 143896; 143897; 143898; 143899; 143900PBMCAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)No31.01NoYes-Currently Smokes300.5YesNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66639 130258 Male 46-60 Caucasian Cryopreserved 1 mL 2 10M B12/QOD Magnesium/QOD Zinc/QOD Potassium Citrate Vitamin C/QOD Lions mane/QOD Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144977; 144978PBMCAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)YesRed meat25.82NoNoNoNOYesStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66839 129422 Male 31-45 Caucasian Cryopreserved 1 mL 4 10M Sertraline 50 mg QD Zyrtec 20 mg BID Epi Pen PRN Pepcid 20 mg BID Singulair 10 mg QD Ativan 0.5 mg PRN Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144347; 144348; 144349; 144350PBMCAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)YesMeat22.96NoNoNoNONoStoredIn Stock
$530
Alpha-Gal Syndrome (AGS) PBMC 66721 128332 Female 31-45 Caucasian Cryopreserved 1 mL 3 10M — Alpha-Gal Syndrome (AGS) United States 2025 — — — — — — — — — 144290; 144291; 144289PBMCAlpha-Gal Syndrome (AGS)Alpha-Gal Syndrome (AGS)No18.79NoUsed to Smoke81NoNONoStoredIn Stock
$530

Showing 1–5 of 5 lots

About Alpha-Gal Syndrome PBMC

Alpha-Gal Syndrome PBMC for IgE-Mediated Allergy Research

Human Alpha-Gal Syndrome PBMC products are sourced from donors clinically diagnosed with alpha-gal syndrome and processed under stringent conditions. Alpha-gal syndrome is an IgE-mediated, type 2 immune (allergic) condition: sensitization to the carbohydrate galactose-alpha-1,3-galactose follows tick bites, driven in the United States by the lone star tick, Amblyomma americanum. These cryopreserved peripheral blood mononuclear cells (PBMCs) support basophil activation testing, allergen-specific T cell work, and effector-cell studies.

Alpha-Gal Immunology and Why PBMC

  • IgE to alpha-gal: sensitized donors carry specific IgE against galactose-alpha-1,3-galactose, a glycan present on non-primate mammalian tissue but absent in humans and Old World primates.
  • Tick-bite sensitization: bites from Amblyomma americanum in the US, and related ixodid ticks elsewhere, drive class switching to alpha-gal-specific IgE. Repeated bites can boost levels, and sensitization may wane if further bites are avoided.
  • Characteristically delayed reactions: symptoms typically begin 3 to 6 hours after eating mammalian meat, because the allergen is carried on chylomicrons and other lipid particles and only reaches the circulation after digestion and lipid processing. This distinguishes alpha-gal syndrome from the immediate onset of most food allergies.
  • Effector cells: basophils and mast cells bearing Fc-epsilon-RI-bound alpha-gal-specific IgE are the proximal effectors, which makes PBMCs the correct specimen for basophil activation testing using CD63 and CD203c upregulation on the donor’s own cells.
  • Allergen-specific T cells: Th2 responses and the IL-4 and IL-13-driven B cell help behind IgE production can be interrogated by stimulating donor PBMCs with alpha-gal-bearing glycoproteins.
  • Clinically important cross-reactivity: alpha-gal IgE underlies hypersensitivity to cetuximab and can affect gelatin-containing products and some bovine or porcine-derived medical materials, making donor cells useful for biologic and device immunogenicity testing.

Donor Stratification Available

  • Alpha-gal-specific IgE positive by clinical serology where documented
  • Reaction severity: cutaneous-predominant, gastrointestinal-predominant, or a history of anaphylaxis
  • Documented tick-bite exposure history and geographic region
  • Trigger profile: red meat, organ meat, dairy, or gelatin sensitivity
  • Concurrent atopy: asthma, allergic rhinitis, atopic dermatitis, or additional food allergy
  • Time since diagnosis and current avoidance status
  • Matched healthy controls available, including non-sensitized donors from tick-endemic regions

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed Alpha-Gal Syndrome donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified Alpha-Gal Syndrome diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies, atopic history, and infectious disease history
  • Tick-bite history and reaction profile where documented
  • Additional Alpha-Gal Syndrome-specific data available upon request

Applications

  • Basophil activation testing with alpha-gal glycoconjugates
  • Allergen-specific T cell proliferation and cytokine response assays
  • Basophil and mast cell degranulation mechanism studies
  • Th2 cytokine and IgE class-switch pathway analysis
  • Anti-IgE and IgE-pathway therapeutic screening
  • Cetuximab and biologic hypersensitivity research
  • Transcriptomic and proteomic profiling of sensitized versus non-sensitized donors
  • Diagnostic and assay development for alpha-gal sensitization

Other Alpha-Gal Syndrome Specimen Types

Compliance and Quality Assurance

  • IRB-approved collections and protocols
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Customization

Alpha-Gal Syndrome PBMC samples are shipped on dry ice and available in custom aliquots. For pricing, current availability, international orders, or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs. To browse other conditions and live stock status, visit our human PBMC page.

Applications

  • Immunology and translational research
  • Biomarker discovery and validation
  • Drug screening and assay development
  • Vaccine and infectious disease research

Product Features

  • Research Use Only (RUO), PBMC
  • Sourced from screened, consented donors
  • Processed under validated SOPs
  • QC tested for purity, viability, and sterility
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified diagnosis and clinical history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human PBMC are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Alpha-Gal Syndrome PBMC with normal donor samples for comparison

Healthy Donor PBMCs

705 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information